Evidence map›Paper›PMID 36361584›Full record

ArticleInternational journal of molecular sciences2022

Methotrexate-Induced Alteration of Renal Aquaporins 1 and 2, Oxidative Stress and Tubular Apoptosis Can Be Attenuated by Omega-3 Fatty Acids Supplementation.

Mosaab Salah El-Din El-Agawy, Alaa Mohamed Mohamed Badawy, Mohammed R Rabei, Mohamed Mahmoud Abdelraheem Elshaer, Eman Mohamad El Nashar, Mansour A Alghamdi, Mohammed A Alshehri, Hassan Reda Hassan Elsayed

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Mosaab Salah El-Din El-AgawyDepartment of Anatomy and Embryology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
Alaa Mohamed Mohamed BadawyDepartment of Anatomy and Embryology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
Mohammed R RabeiDepartment of Medical Physiology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.ORCID 0000-0001-9685-7399
Mohamed Mahmoud Abdelraheem ElshaerDepartment of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.
Eman Mohamad El NasharDepartment of Anatomy, College of Medicine, King Khalid University, Abha 61421, Saudi Arabia.ORCID 0000-0002-2883-6761
Mansour A AlghamdiDepartment of Anatomy, College of Medicine, King Khalid University, Abha 61421, Saudi Arabia.ORCID 0000-0002-6613-1498
Mohammed A AlshehriNephrology Section, Internal Medicine Department, College of Medicine, King Khalid University, Abha 61421, Saudi Arabia.ORCID 0000-0001-5355-5868
Hassan Reda Hassan ElsayedDepartment of Anatomy and Embryology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.ORCID 0000-0002-3489-3279
Mansoura University · EGKing Khalid University · SAAin Shams University · EGBenha University · EG

Funding

King Khalid University R.G.P. 2/143/43
6 · The paper itself

Abstract

Methotrexate (MTX) is a potent anti-cancer drug, commonly associated with nephrotoxicity via the induction of oxidative stress and apoptosis with alteration of renal water channel proteins, namely aquaporins (AQPs). Omega-3 long-chain polyunsaturated fatty acids (LC-PUFA) have shown cytoprotective effects through their anti-oxidant and antiapoptotic activities. The present study aims for the first time to explore the role of LC-PUFA against MTX-induced nephrotoxicity. Rats were divided into the following groups: saline control, LC-PUFA control, MTX, MTX + LC-PUFA (150 mg/kg), or MTX + LC-PUFA (300 mg/kg). Then, H&E staining and immunohistochemical staining for the anti-apoptosis marker B-cell lymphoma 2 (BCL-2), the apoptosis marker BCL2-Associated X Protein (BAX), the proinflammatory marker Nuclear factor kappa B (NF-kB), AQPs 1 and 2 were performed in kidney sections with an assessment of renal oxidative stress. The MTX caused a renal histopathological alteration, upregulated renal BAX and NF-kB, downregulated Bcl-2 and AQP1, altered the distribution of AQP2, and caused oxidative stress. The LC-PUFA attenuated the pathological changes and decreased renal BAX and NF-kB, increased BCL-2 and AQP1, restored the normal distribution of AQP2, and decreased the oxidative stress. Therefore, LC-PUFA is a good adjuvant to MTX to prevent its adverse effects on kidneys through its antiapoptotic, antioxidant, and anti-inflammatory effect and its role in the restoration of the expression of AQPs 1 and 2.

Indexed as

Fatty Acids, Omega-3MethotrexateAnimalsAntioxidantsAquaporin 2bcl-2-Associated X ProteinDietary SupplementsKidneyNF-kappa BOxidative StressProto-Oncogene Proteins c-bcl-2RatsAntioxidantsAquaporin 2bcl-2-Associated X ProteinFatty Acids, Omega-3MethotrexateNF-kappa BProto-Oncogene Proteins c-bcl-2apoptosisaquaporinskidneymethotrexateomega-3 fatty acidsoxidative stress

Identifiers

PMID36361584
PMCPMC9653681
OpenAlexW4307267863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.